<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 3.3b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: XBRL OPRX.xfr; Date: 2012/08/14T17:42:54 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:us-roles="http://fasb.org/us-roles/2012-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:OPRX="http://OPRX/20120630">
    <link:schemaRef xlink:href="oprx-20120630.xsd" xlink:type="simple" />
    <xbrli:context id="From2012-04-01to2012-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-04-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2011-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-04-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-04-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-05-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-05-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-11-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-11-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-09-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-09-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-12-01to2014-12-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-12-01</xbrli:startDate>
        <xbrli:endDate>2014-12-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2007-10-22to2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-10-22</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-10-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-04-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-04-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-11-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-11-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2010-01-01to2010-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2010-01-01</xbrli:startDate>
        <xbrli:endDate>2010-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2008-01-01to2008-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2008-01-01</xbrli:startDate>
        <xbrli:endDate>2008-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-07-01to2011-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-07-01</xbrli:startDate>
        <xbrli:endDate>2011-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-10-01to2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-10-01</xbrli:startDate>
        <xbrli:endDate>2011-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2032-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2032-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-06-30_PreviouslyStatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:PreviouslyStatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-04-01to2011-06-30_PreviouslyStatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">OPRX:PreviouslyStatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-04-01</xbrli:startDate>
        <xbrli:endDate>2011-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-07-01to2013-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-07-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2012-04-01to2012-06-30">OptimizeRx Corp</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2012-04-01to2012-06-30">0001448431</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2012-04-01to2012-06-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2012-04-01to2012-06-30">2012-06-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2012-04-01to2012-06-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2012-04-01to2012-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2012-04-01to2012-06-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2012-04-01to2012-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2012-04-01to2012-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2012-04-01to2012-06-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2012-04-01to2012-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2012-04-01to2012-06-30">2012</dei:DocumentFiscalYearFocus>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">14192496</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-06-30" unitRef="USDPShares" decimals="INF">.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2011-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">14192496</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">14192496</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2012-06-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2011-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2012-06-30" unitRef="Shares" decimals="INF">65</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">65</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">527511</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">959166</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">526047</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">471870</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">56686</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">119032</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">1110244</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1550068</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">23449</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">23931</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">820589</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">847941</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">455935</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">465498</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:SecurityDeposit contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">5049</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">5049</us-gaap:SecurityDeposit>
    <us-gaap:OtherAssets contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">1281573</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1318488</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">2415266</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">2892487</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">177511</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">336712</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">570000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">570000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">0</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">66000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">1024587</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1303317</us-gaap:LiabilitiesCurrent>
    <us-gaap:CommonStockValue contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">14192</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">14192</us-gaap:CommonStockValue>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">20826934</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">20826934</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">5303862</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">5125558</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">-24754309</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">-24377514</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">1390679</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1589170</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">2415266</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">2892487</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockValue contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:SalesRevenueNet contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">515423</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">844826</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">594017</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">200174</us-gaap:SalesRevenueNet>
    <us-gaap:Revenues contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">515423</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">844826</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">594017</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">200174</us-gaap:Revenues>
    <us-gaap:OperatingExpenses contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">591628</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">1221952</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">1254935</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">620654</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">962435</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2011-04-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">493154</us-gaap:OperatingExpenses>
    <OPRX:Expenses contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">591628</OPRX:Expenses>
    <OPRX:Expenses contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">1221952</OPRX:Expenses>
    <OPRX:Expenses contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">1254935</OPRX:Expenses>
    <OPRX:Expenses contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">620654</OPRX:Expenses>
    <us-gaap:InterestIncomeOperating contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">146</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">331</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">835</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">395</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestExpense contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-66</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">-140098</us-gaap:InterestExpense>
    <us-gaap:OtherExpenses contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">146</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">-139703</us-gaap:OtherExpenses>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">-76059</OPRX:LossBeforeProvisionForIncomeTaxes>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">-560183</OPRX:LossBeforeProvisionForIncomeTaxes>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-647615</OPRX:LossBeforeProvisionForIncomeTaxes>
    <OPRX:LossBeforeProvisionForIncomeTaxes contextRef="From2011-04-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-432683</OPRX:LossBeforeProvisionForIncomeTaxes>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">-76059</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-376795</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-940115</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">-560183</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-647615</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2011-04-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-432683</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2012-04-01to2012-06-30" unitRef="Shares" decimals="INF">14192496</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2012-01-01to2012-06-30" unitRef="Shares" decimals="INF">14192496</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2011-01-01to2011-06-30" unitRef="Shares" decimals="INF">13749300</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2011-04-01to2011-06-30" unitRef="Shares" decimals="INF">13869202</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2012-04-01to2012-06-30" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2012-01-01to2012-06-30" unitRef="USDPShares" decimals="INF">-0.03</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2011-01-01to2011-06-30" unitRef="USDPShares" decimals="INF">-0.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2011-04-01to2011-06-30" unitRef="USDPShares" decimals="INF">-0.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">-76205</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-377126</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-660918</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">-420480</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-368418</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2011-04-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-292980</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-376795</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-940115</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-647615</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">47329</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">93352</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">60100</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">30050</us-gaap:DepreciationAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">250000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-54177</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">85900</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">12268</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-34813</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-158502</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">260852</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-1648</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">30000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-66700</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">25000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-5000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-53529</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-73110</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-375700</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-225479</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-2230</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:CapitalizedComputerSoftwareAmortization contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-53725</us-gaap:CapitalizedComputerSoftwareAmortization>
    <us-gaap:CapitalizedComputerSoftwareAmortization contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-82850</us-gaap:CapitalizedComputerSoftwareAmortization>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-55955</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-82850</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-431655</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-308329</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <OPRX:CashAndCashEquivalentsBeginning contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">959166</OPRX:CashAndCashEquivalentsBeginning>
    <OPRX:CashAndCashEquivalentsBeginning contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">1278094</OPRX:CashAndCashEquivalentsBeginning>
    <OPRX:CashAndCashEquivalentsEnding contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">527511</OPRX:CashAndCashEquivalentsEnding>
    <OPRX:CashAndCashEquivalentsEnding contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">969765</OPRX:CashAndCashEquivalentsEnding>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">250000</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:InterestPaid contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:NatureOfOperations contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Optimizer Systems, LLC was formed in the State&#13;of Michigan on January 31, 2006. It then became a corporation in the State of Michigan on October 22, 2007 and changed its name&#13;to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated a reverse merger by entering into&#13;a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which the stockholders of OptimizeRx Corporation&#13;exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation for 1,256,958 shares of common stock of RFID,&#13;Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April 30, 2008, RFID&amp;#146;s officers and directors&#13;resigned their positions and RFID changed its business to OptimizeRx&amp;#146;s business. On April 15, 2008, RFID, Ltd.&amp;#146;s corporate&#13;name was changed to OptimizeRx Corporation. On September 4, 2008, a migratory merger was completed, thereby changing the state&#13;of incorporation from Colorado to Nevada, resulting in the current corporate structure, in which OptimizeRx Corporation, a Nevada&#13;corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation, is a wholly-owned subsidiary (together,&#13;"OptimizeRx" and "the Company").&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The wholly-owned subsidiary, OptimizeRx Corporation,&#13;is a technology solutions company targeting the health care industry. Their objective is to bring better access to better care&#13;through connecting patients, physicians and pharmaceutical manufacturers through technology. Once defined as a marketing and advertising&#13;company through its consumer website, OptimizeRx is maturing as a technology solutions provider as it launched its direct to physician&#13;solution, SampleMD. SampleMD allows physicians to search, print and send available sample trial vouchers and/or co-pay coupons&#13;on behalf of their patients. The SampleMD solution can either sit on the doctor&amp;#146;s desktop or can be integrated into the ePrescribing&#13;or Electronic Medical Records applications. OptimizeRx solutions provide pharmaceutical manufacturers either a direct to consumer&#13;and/or direct to physician channels for communicating and promoting their products. It provides health care providers a means to&#13;provide sampling and coupons without having to physically store samples on site, and it provides better access and affordability&#13;to the patients.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The accompanying unaudited&#13;interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the&#13;United States of America and the rules of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;), and should be read in conjunction&#13;with the audited financial statements and notes thereto contained in the Company&amp;#146;s Form 10-K filed with the SEC as of and&#13;for the year ended December 31, 2011. In the opinion of management, all adjustments necessary for the financial statements to be&#13;not misleading for the interim periods presented have been reflected herein. The results of operations for interim periods are&#13;not necessarily indicative of the results to be expected for the full year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Accounting Basis&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company uses the accrual basis of accounting&#13;and accounting principles generally accepted in the United States of America (&amp;#147;GAAP&amp;#148; accounting). The Company has adopted&#13;a December 31 fiscal year end.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font-weight: normal"&gt;&lt;u&gt;Principles&#13;of Consolidation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The financial statements&#13;reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation&#13;(a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Reclassifications&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain accounts and financial statement captions&#13;in the prior periods have been reclassified to conform to the current period financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font-weight: normal"&gt;&lt;u&gt;Cash&#13;and Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;For purposes of the&#13;accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months&#13;or less to be cash equivalents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The fair value of cash,&#13;accounts receivable, prepaid expenses, accounts payable, accounts payable &amp;#150; related party, accrued expenses and deferred&#13;revenue approximates the carrying amount of these financial instruments due to their short-term nature. The fair value of long-term&#13;debt, which approximates its carrying value, is based on current rates at which the Company could borrow funds with similar remaining&#13;maturities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The capital assets&#13;are being depreciated over their estimated useful lives, three to seven years using the straight-line method of depreciation for&#13;book purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All revenue is recognized when it is earned.&#13;Revenues are generated either through the Company&amp;#146;s website activities, in which we earn revenue from advertising and lead&#13;generation activities, or from our SampleMD activities, which include offering setup within the systems and our offers, coupons,&#13;and vouchers that enable our customers to save money on medical products and services. The Company&amp;#146;s processes are monitored&#13;by third parties who collect revenues from clients on a per activity basis and report and forward the revenue to the Company&amp;#146;s&#13;account.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income taxes are computed using the asset and&#13;liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the&#13;differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted&#13;tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence,&#13;are not expected to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company&amp;#146;s&#13;key members are part of a continual research development team and monitor new technologies, trends, services and partnerships that&#13;can provide the Company with additional services, value to healthcare and pharmaceutical industries and to the patients it serves.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company seeks to&#13;educate team members through understanding of all market dynamics that have the potential to affect the business both short term&#13;and longer term. The primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as&#13;other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission&#13;through technology, better user experiences and new ways to engage industries to provide new support for patients needing their&#13;products. The Company is always seeking new services and solutions to offer. At this time, the three current platforms provide&#13;robust opportunities and growth during the next five years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Concentration of Credit Risks&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company maintains&#13;its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not&#13;experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences&#13;financial difficulties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The preparation of&#13;financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of&#13;revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives&#13;of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Earnings Per Common and Common Equivalent&#13;Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The computation of&#13;basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The&#13;computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year&#13;plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the&#13;average market price per share during the year. Options, warrants and convertible preferred stock which are common stock equivalents&#13;are not included in the diluted earnings per share calculation for June 30, 2012 and 2011, respectively, since their effect is&#13;anti-dilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Impairment of Long-Lived Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company continually&#13;monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable.&#13;When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining&#13;whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the&#13;future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess&#13;of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount&#13;or the fair value less costs to sell.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Recently Issued Accounting Guidance&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company does not&#13;expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&amp;#146;s results of&#13;operations, financial position or cash flow.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The accompanying unaudited&#13;interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the&#13;United States of America and the rules of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;), and should be read in conjunction&#13;with the audited financial statements and notes thereto contained in the Company&amp;#146;s Form 10-K filed with the SEC as of and&#13;for the year ended December 31, 2011. In the opinion of management, all adjustments necessary for the financial statements to be&#13;not misleading for the interim periods presented have been reflected herein. The results of operations for interim periods are&#13;not necessarily indicative of the results to be expected for the full year.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <OPRX:SignificantAccountingPolicyPoliciesTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Accounting Basis&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company uses the accrual basis of accounting&#13;and accounting principles generally accepted in the United States of America (&amp;#147;GAAP&amp;#148; accounting). The Company has adopted&#13;a December 31 fiscal year end.&lt;/p&gt;</OPRX:SignificantAccountingPolicyPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font-weight: normal"&gt;&lt;u&gt;Principles&#13;of Consolidation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The financial statements&#13;reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation&#13;(a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:Reclassifications contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Reclassifications&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain accounts and financial statement captions&#13;in the prior periods have been reclassified to conform to the current period financial statements.&lt;/p&gt;</us-gaap:Reclassifications>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&lt;font style="font-weight: normal"&gt;&lt;u&gt;Cash&#13;and Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;For purposes of the&#13;accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months&#13;or less to be cash equivalents.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The fair value of cash,&#13;accounts receivable, prepaid expenses, accounts payable, accounts payable &amp;#150; related party, accrued expenses and deferred&#13;revenue approximates the carrying amount of these financial instruments due to their short-term nature. The fair value of long-term&#13;debt, which approximates its carrying value, is based on current rates at which the Company could borrow funds with similar remaining&#13;maturities.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The capital assets&#13;are being depreciated over their estimated useful lives, three to seven years using the straight-line method of depreciation for&#13;book purposes.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All revenue is recognized when it is earned.&#13;Revenues are generated either through the Company&amp;#146;s website activities, in which we earn revenue from advertising and lead&#13;generation activities, or from our SampleMD activities, which include offering setup within the systems and our offers, coupons,&#13;and vouchers that enable our customers to save money on medical products and services. The Company&amp;#146;s processes are monitored&#13;by third parties who collect revenues from clients on a per activity basis and report and forward the revenue to the Company&amp;#146;s&#13;account.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income taxes are computed using the asset and&#13;liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the&#13;differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted&#13;tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence,&#13;are not expected to be realized.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InProcessResearchAndDevelopmentPolicy contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company&amp;#146;s&#13;key members are part of a continual research development team and monitor new technologies, trends, services and partnerships that&#13;can provide the Company with additional services, value to healthcare and pharmaceutical industries and to the patients it serves.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company seeks to&#13;educate team members through understanding of all market dynamics that have the potential to affect the business both short term&#13;and longer term. The primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as&#13;other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission&#13;through technology, better user experiences and new ways to engage industries to provide new support for patients needing their&#13;products. The Company is always seeking new services and solutions to offer. At this time, the three current platforms provide&#13;robust opportunities and growth during the next five years.&lt;/p&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Concentration of Credit Risks&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company maintains&#13;its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not&#13;experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences&#13;financial difficulties.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:UseOfEstimates contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The preparation of&#13;financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of&#13;revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives&#13;of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Earnings Per Common and Common Equivalent&#13;Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The computation of&#13;basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The&#13;computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year&#13;plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the&#13;average market price per share during the year. Options, warrants and convertible preferred stock which are common stock equivalents&#13;are not included in the diluted earnings per share calculation for June 30, 2012 and 2011, respectively, since their effect is&#13;anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Impairment of Long-Lived Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company continually&#13;monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable.&#13;When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining&#13;whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the&#13;future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess&#13;of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount&#13;or the fair value less costs to sell.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;u&gt;Recently Issued Accounting Guidance&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;The Company does not&#13;expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&amp;#146;s results of&#13;operations, financial position or cash flow.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <OPRX:PrepaidExpensesTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;Prepaid expenses consisted&#13;of the following as of June 30, 2012 and December 31, 2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 54%"&gt;Insurance&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;8,078&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;5,937&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Website maintenance&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;17,500&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;5,049&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;41,733&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;91,811&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Employee advances&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,826&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;694&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Advertising&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;3,090&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total prepaid expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;56,686&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;119,032&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:PrepaidExpensesTextBlock>
    <OPRX:ScheduleOfPrepaidExpensesTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 54%"&gt;Insurance&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;8,078&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;5,937&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Website maintenance&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;17,500&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;5,049&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;41,733&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;91,811&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Employee advances&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,826&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;694&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Advertising&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;3,090&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total prepaid expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;56,686&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;119,032&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfPrepaidExpensesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company owned equipment recorded at cost&#13;which consisted of the following as of June 30, 2012 and December 31, 2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Computer equipment&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;22,360&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;20,130&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Furniture and fixtures&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Subtotal&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;31,218&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated depreciation&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(9,999&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(7,287&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Property and equipment, net&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;23,449&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;23,931&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation expense was $2,712 and $906 for&#13;the six months ended June 30, 2012 and 2011, respectively.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <OPRX:ScheduleOfPropertyEquipmentTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Computer equipment&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;22,360&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;20,130&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Furniture and fixtures&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;11,088&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Subtotal&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;31,218&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated depreciation&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(9,999&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(7,287&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Property and equipment, net&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;23,449&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;23,931&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfPropertyEquipmentTextBlock>
    <us-gaap:Depreciation contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">2712</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">906</us-gaap:Depreciation>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">11088</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">11088</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">-9999</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">-7287</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <OPRX:SubtotalOfPropertyEquipmentCost contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">33448</OPRX:SubtotalOfPropertyEquipmentCost>
    <OPRX:SubtotalOfPropertyEquipmentCost contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">31218</OPRX:SubtotalOfPropertyEquipmentCost>
    <OPRX:ComputerEquipmentGross contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">22360</OPRX:ComputerEquipmentGross>
    <OPRX:ComputerEquipmentGross contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">20130</OPRX:ComputerEquipmentGross>
    <OPRX:WebsiteDevelopmentTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has capitalized costs in developing&#13;their website and web-based products, which consisted of the following as of June 30, 2012 and December 31, 2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;OptimizeRx web development&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;SampleMD web development&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;607,602&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;553,877&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Subtotal, web development costs&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;761,735&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;708,010&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(246,717&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(183,429&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Impairment&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Web development costs, net&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;455,935&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;465,498&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company began amortizing the OptimizeRx&#13;website costs, using the straight-line method over the estimated useful life of 5 years, once it was put into service in December&#13;of 2007. During the year ended December 31, 2009, the Company began a new web-based project and the related programming and development&#13;costs have been capitalized for the SampleMD website. The project was completed in mid-December 2010 and no amortization was recorded&#13;in 2010. Amortization began on the straight-line method in January 2011 over the period of five years. Although the Project was&#13;completed in mid-December, the Company continues to enhance and upgrade the website. Monthly payments for these upgrades and enhancements&#13;have been capitalized and amortization was started by quarter in 2011 and continues in 2012. The Company determined that the original&#13;OptimizeRx website was no longer useful so the remaining unamortized balance of $59,083 was impaired as of December 31, 2010.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization expense was $63,288 and $31,841&#13;for the six months ended June 30, 2012 and 2011, respectively.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:WebsiteDevelopmentTextBlock>
    <OPRX:ScheduleOfWebsiteDevelopmentCostsTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;OptimizeRx web development&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;154,133&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;SampleMD web development&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;607,602&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;553,877&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Subtotal, web development costs&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;761,735&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;708,010&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(246,717&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;(183,429&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Impairment&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(59,083&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Web development costs, net&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;455,935&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;465,498&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfWebsiteDevelopmentCostsTableTextBlock>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">-59083</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">-59083</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="AsOf2010-12-31" unitRef="USD" decimals="0">59083</us-gaap:UnamortizedDebtIssuanceExpense>
    <OPRX:WebsiteDevelopmentCost1 contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">154133</OPRX:WebsiteDevelopmentCost1>
    <OPRX:WebsiteDevelopmentCost1 contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">154133</OPRX:WebsiteDevelopmentCost1>
    <OPRX:WebsiteDevelopmentCost2 contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">607602</OPRX:WebsiteDevelopmentCost2>
    <OPRX:WebsiteDevelopmentCost2 contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">553877</OPRX:WebsiteDevelopmentCost2>
    <OPRX:SubtotalofWebsiteDevelopmentCosts contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">761735</OPRX:SubtotalofWebsiteDevelopmentCosts>
    <OPRX:SubtotalofWebsiteDevelopmentCosts contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">708010</OPRX:SubtotalofWebsiteDevelopmentCosts>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">-246717</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <us-gaap:AccumulatedAmortizationOfOtherDeferredCosts contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">-183429</us-gaap:AccumulatedAmortizationOfOtherDeferredCosts>
    <OPRX:WebsiteDevelopmenCostNet contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">455935</OPRX:WebsiteDevelopmenCostNet>
    <OPRX:WebsiteDevelopmenCostNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">465498</OPRX:WebsiteDevelopmenCostNet>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 26, 2010, the Company acquired from&#13;an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD patent currently&#13;in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000&#13;stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the&#13;related party.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has capitalized costs in purchasing&#13;the SampleMD patent, which consisted of the following as of June 30, 2012 and December 31, 2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Patent rights and intangible assets&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;930,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;930,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(109,411&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(82,059&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Patent rights and intangible assets, net&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;820,589&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;847,941&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company began amortizing the patent, using&#13;the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. Amortization expense&#13;was $27,352 and $27,353 for the six months ended June 30, 2012 and 2011, respectively.&lt;/p&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Patent rights and intangible assets&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;930,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;930,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accumulated amortization&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(109,411&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(82,059&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Patent rights and intangible assets, net&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;820,589&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;847,941&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <OPRX:ShareBasedCompensationArrangementofStockOptionsIssued contextRef="AsOf2010-12-31" unitRef="Shares" decimals="INF">300000</OPRX:ShareBasedCompensationArrangementofStockOptionsIssued>
    <OPRX:ShareBasedCompensationArrangementofStockOptionsIssued contextRef="AsOf2010-04-26" unitRef="Shares" decimals="INF">200000</OPRX:ShareBasedCompensationArrangementofStockOptionsIssued>
    <OPRX:ShareBasedCompensationArrangementofStockOptionsValue contextRef="AsOf2010-12-31" unitRef="USD" decimals="0">360000</OPRX:ShareBasedCompensationArrangementofStockOptionsValue>
    <OPRX:ShareBasedCompensationArrangementofStockOptionsValue contextRef="AsOf2010-04-26" unitRef="USD" decimals="0">360000</OPRX:ShareBasedCompensationArrangementofStockOptionsValue>
    <OPRX:CommonStockValueOnGrantDate contextRef="AsOf2010-12-31" unitRef="USD" decimals="0">570000</OPRX:CommonStockValueOnGrantDate>
    <OPRX:CommonStockValueOnGrantDate contextRef="AsOf2010-04-26" unitRef="USD" decimals="0">570000</OPRX:CommonStockValueOnGrantDate>
    <OPRX:AmortizationExpenseofPatent contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">27353</OPRX:AmortizationExpenseofPatent>
    <OPRX:AmortizationExpenseofPatent contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">27353</OPRX:AmortizationExpenseofPatent>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">930000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">930000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
    <OPRX:AccumulatedAmortizationOfPatentRights contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">-109411</OPRX:AccumulatedAmortizationOfPatentRights>
    <OPRX:AccumulatedAmortizationOfPatentRights contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">-82059</OPRX:AccumulatedAmortizationOfPatentRights>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">820589</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">847941</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <OPRX:AmortizationExpenseofWebsite contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">63288</OPRX:AmortizationExpenseofWebsite>
    <OPRX:AmortizationExpenseofWebsite contextRef="AsOf2011-06-30" unitRef="USD" decimals="0">31841</OPRX:AmortizationExpenseofWebsite>
    <OPRX:AccruedExpenseTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accrued expenses consisted of the following&#13;as of June 30, 2012 and December 31, 2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/6pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Accrued payroll taxes&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accrued bonuses&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;60,000&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accrued audit fees&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;6,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total accrued expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;66,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</OPRX:AccruedExpenseTextBlock>
    <OPRX:ScheduleOfAccruedExpensesTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 54%"&gt;Accrued payroll taxes&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Accrued bonuses&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;60,000&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Accrued audit fees&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;6,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total accrued expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;66,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfAccruedExpensesTableTextBlock>
    <us-gaap:DeferredRevenueDisclosureTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font-size: 10pt"&gt;The Company has signed several contracts with customers for coupon redemptions&#13;on their website. The payments are not taken into revenue until the end user redeems the coupon. The redemptions are tracked via&#13;their website and revenues are recorded as the coupons are redeemed. Additionally, customer setup contracts that have been paid&#13;in full are deferred until the Company has completed the obligations of the contracts. Deferred revenue was $277,076 and $330,605&#13;as of June 30, 2012 and December 31, 2011, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:DeferredRevenueDisclosureTextBlock>
    <OPRX:CommonStockTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;OptimizeRx Corporation has 500,000,000 shares&#13;of $.001 par value common stock authorized as of June 30, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 30, 2011, the Company entered into&#13;a settlement agreement with Midtown Partners. Under the settlement agreement, the Company will pay Midtown Partners $57,500 and&#13;grant 100,000 shares of its common stock. The cost of the settlement has been recorded as equity issuance costs. As a result of&#13;the settlement, the litigation in the Eastern District of Michigan was dismissed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2011, the&#13;Company issued 475,820 shares of common stock to satisfy $500,000 of preferred dividends.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There were 14,192,496 common shares issued&#13;and outstanding at June 30, 2012 and December 31, 2011, respectively.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:CommonStockTextBlock>
    <OPRX:CommonStockSharesIssuedForPreferredDividends contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">475820</OPRX:CommonStockSharesIssuedForPreferredDividends>
    <OPRX:StockGrantedDuringPeriodSharesUnderSettlementAgreement contextRef="AsOf2011-06-30" unitRef="Shares" decimals="INF">100000</OPRX:StockGrantedDuringPeriodSharesUnderSettlementAgreement>
    <OPRX:DividendsPreferredStockValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">500000</OPRX:DividendsPreferredStockValue>
    <us-gaap:PreferredStockTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Series A Preferred&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2008, 35&#13;preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in net proceeds of $2,985,000. The 35 shares&#13;are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued&#13;to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of seven years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The holders of the preferred stock are entitled&#13;to semi-annual dividends payable on the stated value of the Series A preferred stock at a rate of 10% per annum, which shall be&#13;cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock&#13;at management&amp;#146;s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive&#13;trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders&#13;can be required to convert their shares to common stock. Each share of Series A preferred stock shall also be convertible at the&#13;option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1 conversion&#13;price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The holder may cause this conversion at the&#13;time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at&#13;any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. There is no&#13;conversion expiration date, however, the holder must provide 30 days notice for the registration of the conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 12, 2010, the Company&amp;#146;s Board&#13;declared and issued 236,598 common shares as payment for all cumulative and current semi-annual dividends. On November 16, 2010,&#13;the Company&amp;#146;s Board declared and issued 173,922 common shares for its semi-annual dividend payment. On March 25, 2011, the&#13;Company&amp;#146;s Board declared and issued 176,768 common shares for its semi-annual dividend payment. On September 21, 2011, the&#13;Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Series B Preferred&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2010, 15&#13;preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock and bear a 10% cumulative&#13;dividend. In addition, there was a warrant issued to purchase 2,000,000 shares of common stock at an exercise price of $3 for a&#13;period of seven years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preferred stock was issued for $1,500,000&#13;less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally, 3,000,000 common stock warrants were issued&#13;with the preferred stock. Based on the fair values of the preferred stock and common stock warrants on the issue date, $341,100&#13;was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants. Equity issuance costs of $350,000 were&#13;allocated to the preferred stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended September 30, 2011,&#13;15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of common stock&#13;and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000 shares of common stock at an&#13;exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock and common stock warrants on&#13;the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 11.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;The holders of the preferred&#13;stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock at a rate of 10% per annum,&#13;which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's&#13;common stock at management&amp;#146;s discretion. If after the conversion eligibility date, the market price for the common stock&#13;for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day,&#13;the preferred shareholders can be required to convert their shares to common stock. Each share of Series B preferred stock shall&#13;also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value&#13;of such share at a $1.50 conversion price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The holder may cause this conversion at the&#13;time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at&#13;any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. On March 25,&#13;2011, the Company&amp;#146;s Board declared and issued 75,758 common shares for its semi-annual dividend payment. On September 21,&#13;2011, the Company's Board declared and issued 66,988 common shares for its semi-annual dividend payment.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2010-05-12" unitRef="Shares" decimals="INF">236598</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2010-11-16" unitRef="Shares" decimals="INF">173922</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2011-03-25" unitRef="Shares" decimals="INF">176768</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA contextRef="AsOf2011-09-21" unitRef="Shares" decimals="INF">156306</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesA>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB contextRef="AsOf2011-03-25" unitRef="Shares" decimals="INF">75758</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB>
    <OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB contextRef="AsOf2011-09-21" unitRef="Shares" decimals="INF">66988</OPRX:CommonStockSharesIssuedForDividendPaymentForSeriesB>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company signed a lease for new office space&#13;on December 1, 2011 at an approximate rent of $5,000 per month. The new offices are in Rochester, Michigan. The lease is for three&#13;years with an option to renew for an additional two years at approximately $5,200 per month with six months advance notice to exercise&#13;the option. Minimum annual rent is as follows for the initial term of the lease and the first six month renewal:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right; width: 63%"&gt;Twelve months ended June 30, 2013&lt;/td&gt;&#13;    &lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 31%"&gt;60,591&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;2014&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;55,542&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;2015&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;Total lease commitment&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;116,133&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:ScheduleOfRentExpenseTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right; width: 63%"&gt;Twelve months ended June 30, 2013&lt;/td&gt;&#13;    &lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 31%"&gt;60,591&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;2014&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;55,542&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;2015&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: right"&gt;Total lease commitment&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;116,133&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: left"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfRentExpenseTableTextBlock>
    <OPRX:CommonStockIssuedForPurchaseOfPatent contextRef="AsOf2010-12-31" unitRef="Shares" decimals="INF">200000</OPRX:CommonStockIssuedForPurchaseOfPatent>
    <OPRX:CommonStockIssuedForPurchaseOfPatent contextRef="AsOf2010-04-26" unitRef="Shares" decimals="INF">300000</OPRX:CommonStockIssuedForPurchaseOfPatent>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The Company had two major customers that accounted&#13;for 53% and one major customer that accounted for 50% of the Company&amp;#146;s revenues for the six months ended June 30, 2012 and&#13;2011, respectively. The Company expects to continue to maintain these relationships with the customers.&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <OPRX:MajorCustomers contextRef="From2012-01-01to2012-06-30" unitRef="Percent" decimals="INF">0.53</OPRX:MajorCustomers>
    <OPRX:MajorCustomers contextRef="From2011-01-01to2011-06-30" unitRef="Percent" decimals="INF">0.50</OPRX:MajorCustomers>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the six months ended June 30, 2012, the&#13;Company incurred a net loss of approximately $377,000 and therefore has no tax liability. The Company began operations in 2007&#13;and has previous net operating loss carry-forwards of $13,479,000 through December 31, 2011. The cumulative loss of $13,856,000&#13;will be carried forward and can be used through the year 2032 to offset future taxable income. In the future, the cumulative net&#13;operating loss carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences&#13;between book and tax reporting.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The provision for Federal income tax consists&#13;of the following for the six months ended June 30, 2012 and 2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Federal income tax benefit attributable to:&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Current operations&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;128,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;220,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(128,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(220,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net provision for federal income tax&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The cumulative tax effect at the expected rate&#13;of 34% of significant items comprising our net deferred tax amount is as follows as of June 30, 2012 and December 31, 2011:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Deferred tax asset attributable to:&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Net operating loss carryover&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,711,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,583,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,711,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,583,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Due to the change in ownership provisions&#13;of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $13,856,000 for Federal income tax reporting&#13;purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited&#13;as to use in future years.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Federal income tax benefit attributable to:&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Current operations&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;128,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;220,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(128,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(220,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net provision for federal income tax&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Deferred tax asset attributable to:&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;Net operating loss carryover&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,711,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;4,583,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,711,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(4,583,000&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;0&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <OPRX:OperatingIncomeLossRounded contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">377000</OPRX:OperatingIncomeLossRounded>
    <OPRX:OperatingIncomeLossRounded contextRef="From2007-10-22to2011-12-31" unitRef="USD" decimals="0">13479000</OPRX:OperatingIncomeLossRounded>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">-128000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">-220000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <OPRX:NetFederalIncomeTax contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">0</OPRX:NetFederalIncomeTax>
    <OPRX:NetFederalIncomeTax contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">0</OPRX:NetFederalIncomeTax>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">4711000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">4583000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">-4711000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">-4583000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2012-06-30" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During the year ended December 31, 2010, the Company&#13;acquired from an officer and shareholder the technical contributions and assignment of all exclusive rights to and for the SampleMD&#13;patent currently in process in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition&#13;to 200,000 stock options valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a&#13;payable to the related party.&lt;/font&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <OPRX:GoingConcernTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying financial statements have&#13;been prepared assuming that the Company will continue as a going concern. The Company has sustained substantial losses since inception.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In view of this matter, the ability of the&#13;Company to continue as a going concern is dependent upon growth of revenues and the ability of the Company to raise additional&#13;capital. Management believes that its successful ability to raise capital and increases in revenues will provide the opportunity&#13;for the Company to continue as a going concern.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:GoingConcernTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In accordance with ASC 855-10, the Company has analyzed&#13;its operations subsequent to June 30, 2012 through the date these financial statements were issued and has determined that it&#13;does not have any material subsequent events to disclose in these financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <OPRX:StockOptionsWarrantsTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The Company accounts for employee stock-based compensation&#13;in accordance with the guidance of ASC Topic 718: Compensation - Stock Compensation, which requires all share-based payments to&#13;employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company follows ASC Topic 505-50, formerly&#13;EITF 96-18, &amp;#147;Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with&#13;Selling Goods and Services,&amp;#148; for stock options and warrants issued to consultants and other non-employees. In accordance&#13;with ASC Topic 505-50, these stock options and warrants issued as compensation for services provided to the Company are accounted&#13;for based upon the fair value of the services provided or the estimated fair market value of the option or warrant, whichever can&#13;be more clearly determined. The fair value of the equity instrument is charged directly to compensation expense and additional&#13;paid-in capital over the period during which services are rendered.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 1, 2010, the Company issued 25,000&#13;stock options to an employee with a vesting period of one year and an exercise price of $1.21. The options were valued on the grant&#13;date using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of&#13;241%, risk-free interest rate of 1.26% and expected life of 60 months. The Company recognized share-based compensation expense&#13;of $6,203 during the year ended December 31, 2010 with the remaining balance of $18,610 recognized in 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 27, 2011, the Company issued 100,000&#13;stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes&#13;option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 221%, risk-free interest rate&#13;of 2.06% and expected life of 60 months. The agreement is for a period of six months. The Company recognized expenses of $83,992&#13;during the year ended December 31, 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 31, 2011, the Company issued 285,000&#13;stock options to 3 employees at an exercise price of $1.00. The options were valued on the grant date using the Black-Scholes option-pricing&#13;model with the following assumptions: dividend yield of 0%, expected volatility of 218%, risk-free interest rate of 1.68% and expected&#13;life of 60 months. The total value of the options was $320,585. The options vest over one year. The Company recognized share-based&#13;compensation expense of $187,005 during the year ended December 31, 2011. The remaining balance of $133,580 has been recognized&#13;during the six months ended June 30, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended September 30, 2011,&#13;there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years.&#13;In addition, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,500,000 shares of&#13;common stock and bear a 10% cumulative dividend. Based on the fair values of the preferred stock and common stock warrants on the&#13;issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 10.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended December 31, 2011,&#13;the Company issued 20,000 stock options to 2 employees at an exercise price of $1.00. The options were valued on the grant date&#13;using the Black-Scholes option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 204-205%,&#13;risk-free interest rate of 0.88-0.93% and expected life of 60 months. The total value of the options was $19,270. The options vest&#13;over one year. The Company recognized share-based compensation expense of $2,480 during the year ended December 31, 2011 and $9,633&#13;during the six months ended June 30, 2012. The remaining balance of $7,154 will be recognized over the next six months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 21, 2011, the Company issued 100,000&#13;stock options to an individual at an exercise price of $0.73. The options were valued on the grant date using the Black-Scholes&#13;option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 205%, risk-free interest rate&#13;of 0.92% and expected life of 60 months. The total value of the options was $100,157. The Company recognized expenses of $8,346&#13;during the year ended December 31, 2011 and $50,078 during the six months ended June 30, 2012. The remaining balance will be recognized&#13;over the current year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 17, 2012, the Company issued 50,000&#13;stock options to 4 non-employees at an exercise price of $0.89. The options were valued on the grant date using the Black-Scholes&#13;option-pricing model with the following assumptions: dividend yield of 0%, expected volatility of 198%, risk-free interest rate&#13;of 0.65% and expected life of 48 months. The total value of the options was $35,091. The options vest over 4 months. The Company&#13;recognized expenses of $35,091 during the six months ended June 30, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</OPRX:StockOptionsWarrantsTextBlock>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2010-10-01">P1Y</OPRX:StockOptionVestingPeriod>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2011-04-27">P6M</OPRX:StockOptionVestingPeriod>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2011-05-31">P1Y</OPRX:StockOptionVestingPeriod>
    <OPRX:StockOptionVestingPeriod contextRef="AsOf2012-03-31">P4M</OPRX:StockOptionVestingPeriod>
    <OPRX:EmployeeShareBasedCompensationExpense contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">6203</OPRX:EmployeeShareBasedCompensationExpense>
    <OPRX:EmployeeShareBasedCompensationExpense contextRef="From2011-01-01to2011-12-31" unitRef="USD" decimals="0">18610</OPRX:EmployeeShareBasedCompensationExpense>
    <OPRX:EmployeeStockOptionIssuance contextRef="AsOf2010-10-01" unitRef="Shares" decimals="INF">25000</OPRX:EmployeeStockOptionIssuance>
    <OPRX:IndividualStockOptionIssuance contextRef="AsOf2011-04-27" unitRef="Shares" decimals="INF">100000</OPRX:IndividualStockOptionIssuance>
    <OPRX:IndividualStockOptionExpense contextRef="From2011-01-01to2011-12-31" unitRef="USD" decimals="0">83992</OPRX:IndividualStockOptionExpense>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2010-10-01" unitRef="USDPShares" decimals="INF">1.21</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2011-04-27" unitRef="USDPShares" decimals="INF">0.73</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2011-05-31" unitRef="USDPShares" decimals="INF">1.00</OPRX:StockOptionExercisePricePerShare>
    <OPRX:StockOptionExercisePricePerShare contextRef="AsOf2011-11-21" unitRef="USDPShares" decimals="INF">.73</OPRX:StockOptionExercisePricePerShare>
    <OPRX:EmployeesStockOptionIssuance contextRef="AsOf2011-05-31" unitRef="Shares" decimals="INF">285000</OPRX:EmployeesStockOptionIssuance>
    <OPRX:EmployeesShareBasedCompensationExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">133580</OPRX:EmployeesShareBasedCompensationExpense>
    <OPRX:EmployeesShareBasedCompensationExpense contextRef="From2011-01-01to2011-12-31" unitRef="USD" decimals="0">187005</OPRX:EmployeesShareBasedCompensationExpense>
    <OPRX:EquityIssuanceCost contextRef="AsOf2011-06-30" unitRef="USD" decimals="0">57500</OPRX:EquityIssuanceCost>
    <OPRX:ConvertiblePreferredStockSeriesASharesIssuedUponConversion contextRef="From2008-01-01to2008-12-31" unitRef="Shares" decimals="INF">3500000</OPRX:ConvertiblePreferredStockSeriesASharesIssuedUponConversion>
    <OPRX:CommonStockWarrantsIssuedForPurchase contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">2000000</OPRX:CommonStockWarrantsIssuedForPurchase>
    <OPRX:CommonStockWarrantsIssuedForPurchase contextRef="From2008-01-01to2008-12-31" unitRef="Shares" decimals="INF">6000000</OPRX:CommonStockWarrantsIssuedForPurchase>
    <OPRX:CommonStockWarrantsIssuedForPurchase contextRef="From2011-07-01to2011-09-30" unitRef="Shares" decimals="INF">1000000</OPRX:CommonStockWarrantsIssuedForPurchase>
    <OPRX:PreferredStockSeriesAValue contextRef="From2008-01-01to2008-12-31" unitRef="USD" decimals="0">3500000</OPRX:PreferredStockSeriesAValue>
    <OPRX:PreferredStockSeriesAStockIssuanceExpense contextRef="From2008-01-01to2008-12-31" unitRef="USD" decimals="0">515000</OPRX:PreferredStockSeriesAStockIssuanceExpense>
    <OPRX:PreferredStockSeriesAStockNetProceeds contextRef="From2008-01-01to2008-12-31" unitRef="USD" decimals="0">2985000</OPRX:PreferredStockSeriesAStockNetProceeds>
    <OPRX:PreferredStockSeriesAStockDividendRatePercentage contextRef="From2008-01-01to2008-12-31" unitRef="Percent" decimals="INF">0.10</OPRX:PreferredStockSeriesAStockDividendRatePercentage>
    <OPRX:PreferredStockSeriesASharesIssuedForProceeds contextRef="From2008-01-01to2008-12-31" unitRef="Shares" decimals="INF">35</OPRX:PreferredStockSeriesASharesIssuedForProceeds>
    <OPRX:PreferredStockSeriesBSharesIssuedForProceeds contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">15</OPRX:PreferredStockSeriesBSharesIssuedForProceeds>
    <OPRX:PreferredStockSeriesBSharesIssuedForProceeds contextRef="From2011-07-01to2011-09-30" unitRef="Shares" decimals="INF">15</OPRX:PreferredStockSeriesBSharesIssuedForProceeds>
    <OPRX:PreferredStockSeriesBValue contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">1500000</OPRX:PreferredStockSeriesBValue>
    <OPRX:PreferredStockSeriesBValue contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">1500000</OPRX:PreferredStockSeriesBValue>
    <OPRX:ConvertiblePreferredStockSeriesBSharesIssuedUponConversion contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">1500000</OPRX:ConvertiblePreferredStockSeriesBSharesIssuedUponConversion>
    <OPRX:ConvertiblePreferredStockSeriesBSharesIssuedUponConversion contextRef="From2011-07-01to2011-09-30" unitRef="Shares" decimals="INF">1500000</OPRX:ConvertiblePreferredStockSeriesBSharesIssuedUponConversion>
    <OPRX:PreferredStockSeriesBStockDividendRatePercentage contextRef="From2010-01-01to2010-12-31" unitRef="Percent" decimals="INF">0.10</OPRX:PreferredStockSeriesBStockDividendRatePercentage>
    <OPRX:PreferredStockSeriesBStockDividendRatePercentage contextRef="From2011-07-01to2011-09-30" unitRef="Percent" decimals="INF">0.10</OPRX:PreferredStockSeriesBStockDividendRatePercentage>
    <OPRX:CommonStockWarrantsExercisePrice contextRef="From2010-01-01to2010-12-31" unitRef="USDPShares" decimals="INF">3</OPRX:CommonStockWarrantsExercisePrice>
    <OPRX:CommonStockWarrantsExercisePrice contextRef="From2008-01-01to2008-12-31" unitRef="USDPShares" decimals="INF">2</OPRX:CommonStockWarrantsExercisePrice>
    <OPRX:CommonStockWarrantsExercisePrice contextRef="From2011-07-01to2011-09-30" unitRef="USDPShares" decimals="INF">3</OPRX:CommonStockWarrantsExercisePrice>
    <OPRX:CommonStockWarrantsExpiration contextRef="From2010-01-01to2010-12-31">P7Y</OPRX:CommonStockWarrantsExpiration>
    <OPRX:CommonStockWarrantsExpiration contextRef="From2008-01-01to2008-12-31">P7Y</OPRX:CommonStockWarrantsExpiration>
    <OPRX:CommonStockWarrantsExpiration contextRef="From2011-07-01to2011-09-30">P7Y</OPRX:CommonStockWarrantsExpiration>
    <OPRX:PreferredStockSeriesBStockIssuanceExpense contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">350000</OPRX:PreferredStockSeriesBStockIssuanceExpense>
    <OPRX:PreferredStockSeriesBStockNetProceeds contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">1150000</OPRX:PreferredStockSeriesBStockNetProceeds>
    <OPRX:PreferredStockValueOnGrantDate contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">341100</OPRX:PreferredStockValueOnGrantDate>
    <OPRX:PreferredStockValueOnGrantDate contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">855460</OPRX:PreferredStockValueOnGrantDate>
    <OPRX:CommonStockWarrantValueOnGrantDate contextRef="From2010-01-01to2010-12-31" unitRef="USD" decimals="0">1158900</OPRX:CommonStockWarrantValueOnGrantDate>
    <OPRX:CommonStockWarrantValueOnGrantDate contextRef="From2011-07-01to2011-09-30" unitRef="USD" decimals="0">644540</OPRX:CommonStockWarrantValueOnGrantDate>
    <OPRX:CommonStockWarrantsIssued contextRef="From2010-01-01to2010-12-31" unitRef="Shares" decimals="INF">3000000</OPRX:CommonStockWarrantsIssued>
    <OPRX:EmployeesStockOptionValue contextRef="AsOf2011-05-31" unitRef="USD" decimals="0">320858</OPRX:EmployeesStockOptionValue>
    <OPRX:Individual2StockOptionIssuance contextRef="AsOf2011-11-21" unitRef="Shares" decimals="INF">100000</OPRX:Individual2StockOptionIssuance>
    <OPRX:Individual2StockOptionValue contextRef="AsOf2011-11-21" unitRef="USD" decimals="0">100157</OPRX:Individual2StockOptionValue>
    <OPRX:Individual2StockOptionExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">50078</OPRX:Individual2StockOptionExpense>
    <OPRX:Individual2StockOptionExpense contextRef="From2011-01-01to2011-12-31" unitRef="USD" decimals="0">8346</OPRX:Individual2StockOptionExpense>
    <OPRX:EmployeesStockOptionIssuance2 contextRef="From2011-10-01to2011-12-31" unitRef="Shares" decimals="INF">20000</OPRX:EmployeesStockOptionIssuance2>
    <OPRX:EmployeesExercisePricePerShare2 contextRef="From2011-10-01to2011-12-31" unitRef="USDPShares" decimals="INF">1.00</OPRX:EmployeesExercisePricePerShare2>
    <OPRX:EmployeesStockOptionValue2 contextRef="From2011-10-01to2011-12-31" unitRef="USD" decimals="0">19270</OPRX:EmployeesStockOptionValue2>
    <OPRX:EmployeesStockOptionVestingPeriod2 contextRef="From2011-10-01to2011-12-31">P1Y</OPRX:EmployeesStockOptionVestingPeriod2>
    <OPRX:EmployeesShareBasedCompensationExpense2 contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">9633</OPRX:EmployeesShareBasedCompensationExpense2>
    <OPRX:EmployeesShareBasedCompensationExpense2 contextRef="From2011-01-01to2011-12-31" unitRef="USD" decimals="0">2480</OPRX:EmployeesShareBasedCompensationExpense2>
    <OPRX:MonthlyRentDue contextRef="From2011-12-01to2014-12-01" unitRef="USD" decimals="0">5000</OPRX:MonthlyRentDue>
    <OPRX:TermOfLease contextRef="From2011-12-01to2014-12-01">P3Y</OPRX:TermOfLease>
    <OPRX:OperatingLossCarryForward contextRef="From2012-01-01to2032-12-31" unitRef="USD" decimals="0">13856000</OPRX:OperatingLossCarryForward>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">128000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">220000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <OPRX:CumulativeTaxEffectiveExpectedRate contextRef="AsOf2012-06-30" unitRef="Percent" decimals="INF">.34</OPRX:CumulativeTaxEffectiveExpectedRate>
    <OPRX:CumulativeTaxEffectiveExpectedRate contextRef="AsOf2011-12-31" unitRef="Percent" decimals="INF">.34</OPRX:CumulativeTaxEffectiveExpectedRate>
    <OPRX:OperatingExpensesTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Operating expenses consisted of the following&#13;for the three months and six months ended June 30, 2012 and 2011, respectively:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: black 1pt solid; text-align: center"&gt;Three months ended June 30,&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: black 1pt solid; text-align: center"&gt;Six months ended June 30,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2011 &lt;br /&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2011 &lt;br /&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;(restated)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;(restated)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 46%"&gt;Advertising&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;32,651&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;118,530&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;43,921&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;305,795&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Professional fees&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;34,632&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;22,683&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;72,635&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;128,897&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,220&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;35,326&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;7,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;82,101&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Salaries, wages and benefits&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;294,570&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;194,912&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;601,465&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;383,626&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,148&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;7,500&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;32,066&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,000&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;47,329&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;30,050&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;93,352&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;60,100&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Stock-based compensation&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;100,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;110,707&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;228,383&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;110,707&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;General and administrative&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;65,243&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;100,946&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;142,295&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;168,709&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Operating Expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;591,628&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;620,654&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,221,952&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,254,935&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:OperatingExpensesTextBlock>
    <OPRX:ScheduleOfOperatingCostAndExpenseByComponentTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: black 1pt solid; text-align: center"&gt;Three months ended June 30,&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="border-bottom: black 1pt solid; text-align: center"&gt;Six months ended June 30,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2011 &lt;br /&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2012&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;2011 &lt;br /&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;(restated)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;(restated)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt; width: 46%"&gt;Advertising&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;32,651&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;118,530&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;43,921&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 10%"&gt;305,795&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Professional fees&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;34,632&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;22,683&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;72,635&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;128,897&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Consulting&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,220&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;35,326&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;7,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;82,101&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Salaries, wages and benefits&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;294,570&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;194,912&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;601,465&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;383,626&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Rent&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,148&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;7,500&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;32,066&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;15,000&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;47,329&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;30,050&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;93,352&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;60,100&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;Stock-based compensation&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;100,835&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;110,707&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;228,383&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;110,707&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;General and administrative&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;65,243&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;100,946&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;142,295&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;168,709&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Operating Expenses&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;591,628&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;620,654&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,221,952&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,254,935&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</OPRX:ScheduleOfOperatingCostAndExpenseByComponentTextBlock>
    <us-gaap:AdvertisingExpense contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">32651</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">43921</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">305795</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">118530</us-gaap:AdvertisingExpense>
    <us-gaap:ProfessionalFees contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">34632</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">72635</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">128897</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">22683</us-gaap:ProfessionalFees>
    <OPRX:Consulting contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">1220</OPRX:Consulting>
    <OPRX:Consulting contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">7835</OPRX:Consulting>
    <OPRX:Consulting contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">82101</OPRX:Consulting>
    <OPRX:Consulting contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">35326</OPRX:Consulting>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">294570</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">601465</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">383626</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">194912</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">65243</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">142295</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">168709</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">100946</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:PaymentsForRent contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">15148</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">32066</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">15000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">7500</us-gaap:PaymentsForRent>
    <us-gaap:ShareBasedCompensation contextRef="From2012-04-01to2012-06-30" unitRef="USD" decimals="0">100835</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-06-30" unitRef="USD" decimals="0">228383</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2011-01-01to2011-06-30" unitRef="USD" decimals="0">110707</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2011-04-01to2011-06-30" unitRef="USD" decimals="0">110707</us-gaap:ShareBasedCompensation>
    <us-gaap:RestatementToPriorYearIncomeTextBlock contextRef="From2012-04-01to2012-06-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has restated its Consolidated Statement&#13;of Operations and its Consolidated Statement of Cash Flows for the three months and six months ended June 30, 2011 to correct an&#13;error in its accounting. The Company did not originally accrue expenses related to advertising, marketing and employee bonuses&#13;during that period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Six months ended &lt;br /&gt;June 30, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 27%; padding-right: 5.4pt"&gt;Financial Statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 45%; padding-right: 5.4pt"&gt;Line Item&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Corrected&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Previously Stated&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Operating expenses&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;1,254,935&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;962,435&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss from operations&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(660,918)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(368,418)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss before provision for income taxes&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(940,115)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(647,615)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Net loss&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(940,115)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(647,615)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Net loss&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(940,115)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(647,615)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Change in accounts payable&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;260,852&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(1,648)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Change in accrued expenses&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;25,000&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(5,000)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Change in payroll taxes payable&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;0&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(700)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Three months ended &lt;br /&gt;June 30, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 27%; padding-right: 5.4pt"&gt;Financial Statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 45%; padding-right: 5.4pt"&gt;Line Item&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Corrected&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Previously Stated&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Operating expenses&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;620,654&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;493,154&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss from operations&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(420,480)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(292,980)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss before provision for income taxes&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(560,183)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(432,683)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Net loss&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(560,183)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(432,683)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:RestatementToPriorYearIncomeTextBlock>
    <OPRX:ScheduleOfRestatedFinancialsForSixMonthsEndedTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Six months ended &lt;br /&gt;June 30, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 27%; padding-right: 5.4pt"&gt;Financial Statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 45%; padding-right: 5.4pt"&gt;Line Item&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Corrected&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Previously Stated&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Operating expenses&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;1,254,935&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;962,435&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss from operations&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(660,918)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(368,418)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss before provision for income taxes&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(940,115)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(647,615)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Net loss&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(940,115)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(647,615)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Net loss&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(940,115)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(647,615)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Change in accounts payable&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;260,852&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(1,648)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Change in accrued expenses&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;25,000&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(5,000)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Statement of cash flows&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Change in payroll taxes payable&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;0&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(700)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfRestatedFinancialsForSixMonthsEndedTableTextBlock>
    <OPRX:ScheduleOfRestatedFinancialsForThreeMonthsEndedTableTextBlock contextRef="From2012-04-01to2012-06-30">&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; padding-right: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Three months ended &lt;br /&gt;June 30, 2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 27%; padding-right: 5.4pt"&gt;Financial Statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; width: 45%; padding-right: 5.4pt"&gt;Line Item&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Corrected&lt;/td&gt;&#13;    &lt;td style="border-bottom: windowtext 1pt solid; text-align: center; padding-left: 5.4pt; layout-grid-mode: line; width: 14%; padding-right: 5.4pt"&gt;Previously Stated&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Operating expenses&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;620,654&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;493,154&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss from operations&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(420,480)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(292,980)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,204); vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Loss before provision for income taxes&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(560,183)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(432,683)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Income statement&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;Net loss&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(560,183)&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; padding-left: 5.4pt; layout-grid-mode: line; padding-right: 5.4pt"&gt;(432,683)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</OPRX:ScheduleOfRestatedFinancialsForThreeMonthsEndedTableTextBlock>
    <OPRX:IncreaseDecreaseInPayrollTax contextRef="From2011-01-01to2011-06-30_PreviouslyStatedMember" unitRef="USD" decimals="0">-700</OPRX:IncreaseDecreaseInPayrollTax>
    <OPRX:MinimumAnnualLeaseAmountDue contextRef="From2012-07-01to2013-06-30" unitRef="USD" decimals="0">60591</OPRX:MinimumAnnualLeaseAmountDue>
    <OPRX:MinimumAnnualLeaseAmountDue contextRef="From2013-07-01to2014-06-30" unitRef="USD" decimals="0">55542</OPRX:MinimumAnnualLeaseAmountDue>
    <OPRX:MinimumAnnualLeaseAmountDue contextRef="From2014-07-01to2015-06-30" unitRef="USD" decimals="0">0</OPRX:MinimumAnnualLeaseAmountDue>
    <OPRX:TotalLeaseCommitmentDue contextRef="From2014-07-01to2015-06-30" unitRef="USD" decimals="0">116133</OPRX:TotalLeaseCommitmentDue>
</xbrli:xbrl>
</XBRL>
